- Headquarters
- Bhopal, Karnataka
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- strainx.in
- Total Funding
- $33.6M
- Last Round
- $6.3M SeedJun 2026
- Rounds
- 4
About
StrainX Bioworks uses synthetic biology and precision fermentation to produce high-value alternative proteins and biomolecules for food, nutraceuticals, and beauty industries. Founded by IIT Delhi alumni, the company engineers custom microbial strains and operates a 10,000-litre fermentation facility in Bhopal, India.
Summary
StraiNX Bioworks is a Biotech company based in Bhopal, United States, founded in 2023. It has raised $33.6M in total across 4 rounds, most recently a $6.3M Seed round in Jun 2026. Investors include Prime Venture Partners, Leo Capital and Wing VC.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company